| ATM associates with and phosphorylates p53: mapping the region of interaction KE Keating, S Kozlov, S Scott, M Gatei, K Hobson, Y Taya, B Gabrielli, ... Nature genetics 20 (4), 398-400, 1998 | 661 | 1998 |
| The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition N Cloonan, MK Brown, AL Steptoe, S Wani, WL Chan, ARR Forrest, ... Genome biology 9, 1-14, 2008 | 366 | 2008 |
| Cdk1/Erk2-and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis M Fabbro, BB Zhou, M Takahashi, B Sarcevic, P Lal, ME Graham, ... Developmental cell 9 (4), 477-488, 2005 | 361 | 2005 |
| Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells L Qiu, A Burgess, DP Fairlie, H Leonard, PG Parsons, BG Gabrielli Molecular biology of the cell 11 (6), 2069-2083, 2000 | 347 | 2000 |
| Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells BG Gabrielli, CPCD Souza, ID Tonks, JM Clark, NK Hayward, KAO Ellem Journal of cell science 109 (5), 1081-1093, 1996 | 297 | 1996 |
| APC mutation and tumour budding in colorectal cancer JR Jass, M Barker, L Fraser, MD Walsh, VLJ Whitehall, B Gabrielli, ... Journal of clinical pathology 56 (1), 69-73, 2003 | 210 | 2003 |
| Histone-deacetylase inhibitors for the treatment of cancer RK Lindemann, B Gabrielli, RW Johnstone Cell cycle 3 (6), 777-786, 2004 | 206 | 2004 |
| Evidence for label-retaining tumour-initiating cells in human glioblastoma LP Deleyrolle, A Harding, K Cato, FA Siebzehnrubl, M Rahman, H Azari, ... Brain 134 (5), 1331-1343, 2011 | 198 | 2011 |
| Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events L De Boer, V Oakes, H Beamish, N Giles, F Stevens, ... Oncogene 27 (31), 4261-4268, 2008 | 196 | 2008 |
| Up-regulation of p21WAF1/CIP1 by histone deacetylase inhibitors reduces their cytotoxicity AJ Burgess, S Pavey, R Warrener, LJK Hunter, TJ Piva, EA Musgrove, ... Molecular pharmacology 60 (4), 828-837, 2001 | 186 | 2001 |
| Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints R Warrener, H Beamish, A Burgess, NJ Waterhouse, N Giles, DP Fairlie, ... The FASEB journal 17 (11), 1-21, 2003 | 181 | 2003 |
| Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events CPC De Souza, KAO Ellem, BG Gabrielli Experimental cell research 257 (1), 11-21, 2000 | 181 | 2000 |
| CDKN2A/p16 Is Inactivated in Most Melanoma Cell Lines M Castellano, PM Pollock, MK Walters, LE Sparrow, LM Down, ... Cancer research 57 (21), 4868-4875, 1997 | 181 | 1997 |
| Histone deacetylase inhibitors specifically kill nonproliferating tumour cells A Burgess, A Ruefli, H Beamish, R Warrener, N Saunders, R Johnstone, ... Oncogene 23 (40), 6693-6701, 2004 | 177 | 2004 |
| RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin LN Putral, MJ Bywater, W Gu, NA Saunders, BG Gabrielli, GR Leggatt, ... Molecular pharmacology 68 (5), 1311-1319, 2005 | 164 | 2005 |
| Cell cycle regulation of the p34cdc2 inhibitory kinases. S Atherton-Fessler, F Liu, B Gabrielli, MS Lee, CY Peng, ... Molecular biology of the cell 5 (9), 989-1001, 1994 | 163 | 1994 |
| MicroRNA-182-5p targets a network of genes involved in DNA repair K Krishnan, AL Steptoe, HC Martin, S Wani, K Nones, N Waddell, ... Rna 19 (2), 230-242, 2013 | 161 | 2013 |
| Regulation of CDC25B phosphatases subcellular localization N Davezac, V Baldin, B Gabrielli, A Forrest, N Theis-Febvre, M Yashida, ... Oncogene 19 (18), 2179-2185, 2000 | 157 | 2000 |
| Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2 BG Gabrielli, JM Clark, AK McCormack, KAO Ellem Journal of Biological Chemistry 272 (45), 28607-28614, 1997 | 156 | 1997 |
| Cdc25B activity is regulated by 14-3-3 A Forrest, B Gabrielli Oncogene 20 (32), 4393-4401, 2001 | 149 | 2001 |
